Published in Vaccine Weekly, March 31st, 2004
According to published research from the United States, "The cholera toxin B subunit (CTB) and a 12-aa HIV-1 Tat transduction peptide were genetically linked to a 90-aa peptide from the murine rotavirus non-structural enterotoxin protein (NSP4) for comparison of receptor directed and transduction peptide mediated antigen targeting to the gut-associated lymphoid tissues for enhanced protection against rotavirus infection. Oral immunization with Tat-NSP490 fusion protein isolated from Escherichia coli generated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.